{"id":"uc-msc","safety":{"commonSideEffects":[{"rate":null,"effect":"Infusion-related reactions"},{"rate":null,"effect":"Infection"},{"rate":null,"effect":"Fever"}]},"_chembl":{"chemblId":"CHEMBL4802046","moleculeType":"Unknown","molecularWeight":"502.55"},"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"Umbilical cord mesenchymal stem cells (UC-MSC) exert therapeutic effects by secreting bioactive factors including cytokines, growth factors, and extracellular vesicles that reduce inflammation, promote angiogenesis, and support tissue repair. These cells can differentiate into multiple cell types and create an immunomodulatory microenvironment that suppresses pathogenic immune responses while supporting regenerative processes.","oneSentence":"UC-MSC is an umbilical cord-derived mesenchymal stem cell therapy that promotes tissue regeneration and modulates immune responses through paracrine signaling.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:51:59.016Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Ulcerative colitis (phase 3)"}]},"trialDetails":[{"nctId":"NCT07479043","phase":"PHASE3","title":"To Evaluate the Safety and Potential Therapeutic Activity of JadiCell™, an Investigational Umbilical Cord-Derived Mesenchymal Stem Cell Therapy, in Patients Diagnosed With Acute Respiratory Distress Syndrome (ARDS).","status":"NOT_YET_RECRUITING","sponsor":"Breathe Biologics, Inc.","startDate":"2026-07","conditions":"Acute Respiratory Distress Syndrome","enrollment":128},{"nctId":"NCT07472270","phase":"PHASE1","title":"Safety Evaluation of MSC-based Therapy for Liver Cihcrosis Treatment","status":"NOT_YET_RECRUITING","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2026-03-15","conditions":"Liver Cirrhosis","enrollment":12},{"nctId":"NCT07449364","phase":"NA","title":"Allogeneic Human Mesenchymal Stem Cell Infusion for Frailty Patient","status":"COMPLETED","sponsor":"Daewoong Group Indonesia","startDate":"2025-03-24","conditions":"Frailty in Older Adults","enrollment":10},{"nctId":"NCT07431645","phase":"PHASE1","title":"Pilot Study of Radiation-Induced Xerostomia Treatment With Allogeneic Mesenchymal Stromal Stem Cells","status":"COMPLETED","sponsor":"Institute of Oncology Ljubljana","startDate":"2023-04-01","conditions":"Radiation-Induced Xerostomia, Head and Neck Cancer","enrollment":10},{"nctId":"NCT07439848","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cells (MSCs) and Conditioned Medium Mesenchymal Stem Cells as Adjuvant Therapy for Sepsis","status":"RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2023-12-25","conditions":"Acute Respiratory Distress Syndrome","enrollment":15},{"nctId":"NCT04314687","phase":"PHASE1, PHASE2","title":"Stem Cell and Conditioned Medium for Cerebral Palsy","status":"ACTIVE_NOT_RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2021-10-13","conditions":"Cerebral Palsy","enrollment":78},{"nctId":"NCT04314661","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cell Therapy (MSCs) and Conditioned Medium Therapy for Osteoartrithis","status":"COMPLETED","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2020-08-03","conditions":"Osteoarthritis, Knee","enrollment":31},{"nctId":"NCT04357600","phase":"PHASE1, PHASE2","title":"Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B","status":"ENROLLING_BY_INVITATION","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2018-05-17","conditions":"Liver Cirrhoses","enrollment":12},{"nctId":"NCT05786287","phase":"","title":"Long-term Safety of UC-MSC Transplantation in Patients With Retinitis Pigmentosa","status":"NOT_YET_RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2026-05","conditions":"Retinitis Pigmentosa","enrollment":18},{"nctId":"NCT05909488","phase":"PHASE2, PHASE3","title":"Role of UC-MSC and CM to Inhibit Vision Loss in Retinitis Pigmentosa Phase I/II","status":"NOT_YET_RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2026-05","conditions":"Retinitis Pigmentosa","enrollment":30},{"nctId":"NCT07429253","phase":"PHASE1, PHASE2","title":"Secretome vs. PRP Injections for Hair Density and Growth in Androgenetic Alopecia Patients","status":"RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2026-01-09","conditions":"Androgenetic Alopecia","enrollment":40},{"nctId":"NCT07299123","phase":"PHASE1, PHASE2","title":"Phase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of SAA","status":"ENROLLING_BY_INVITATION","sponsor":"Chinese PLA General Hospital","startDate":"2023-08-01","conditions":"Severe Aplastic Anemia (SAA), Severe Aplastic Anemia, Refractory, Severe Aplastic Anemia","enrollment":40},{"nctId":"NCT07400328","phase":"PHASE2","title":"Amimestrocel Injection for Preventing Severe Oral Mucositis in HSCT Patients","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2026-01-15","conditions":"Oral Mucositis, Stomatitis, Gastrointestinal Mucositis","enrollment":22},{"nctId":"NCT07396155","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial","status":"RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2026-07-01","conditions":"Diabetic Nephropathy Type 2","enrollment":10},{"nctId":"NCT07337863","phase":"PHASE2, PHASE3","title":"A Phase II/III Randomized Double-Blind Multicenter Study Comparing UC-MSC-Derived Secretome and Sodium Hyaluronate in Patients With Knee Osteoarthritis","status":"NOT_YET_RECRUITING","sponsor":"Universitas Sriwijaya","startDate":"2026-01-01","conditions":"Knee Osteoarthritis (Knee OA)","enrollment":50},{"nctId":"NCT06981741","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of hUC-MSC for the Treatment of Cartilage Damage in the Knee Joint","status":"RECRUITING","sponsor":"BIONCaRT GmbH","startDate":"2025-11-10","conditions":"Cartilage Damage","enrollment":55},{"nctId":"NCT07281690","phase":"PHASE3","title":"Enhancing Skin Rejuvenation Using Laser and Exosomes","status":"COMPLETED","sponsor":"Laser Beamer Skincare","startDate":"2025-03-01","conditions":"Laser Therapy, Exosomes","enrollment":20},{"nctId":"NCT07245875","phase":"NA","title":"Umbilical Cord Mesenchymal Stem Cell Secretome Administration in Severe Erectile Dysfunction Non-responsive to Sildenafil","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2024-04-12","conditions":"Erectile Dysfunction, Diabetes Mellitus Type 2","enrollment":12},{"nctId":"NCT06737380","phase":"PHASE1","title":"UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients","status":"RECRUITING","sponsor":"LiveKidney.Bio","startDate":"2025-01-07","conditions":"SLE, Lupus, Systemic Lupus Erthematosus","enrollment":10},{"nctId":"NCT04869397","phase":"PHASE2","title":"Treatment of Respiratory Complications Associated With COVID-19 Using Umbilical Cord Mesenchymal Stromal Cells","status":"TERMINATED","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2021-06-14","conditions":"Covid19","enrollment":19},{"nctId":"NCT04919135","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem/Stromal Cell Therapy in the Treatment of Frailty","status":"COMPLETED","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2021-10-19","conditions":"Frailty","enrollment":158},{"nctId":"NCT07058025","phase":"PHASE2","title":"Mesenchymal Stromal Cell Therapy to Prevent Bronchopulmonary Dysplasia in Extreme Preterm Infants","status":"NOT_YET_RECRUITING","sponsor":"Ottawa Hospital Research Institute","startDate":"2025-10-01","conditions":"Bronchopulmonary Dysplasia (BPD), ELGAN (22-28SA)","enrollment":168},{"nctId":"NCT07011199","phase":"PHASE1","title":"Clinical Outcomes of Early Kasai Surgery With Umbilical Cord MSCs in Biliary Atresia","status":"NOT_YET_RECRUITING","sponsor":"Universitas Diponegoro","startDate":"2025-06-17","conditions":"Biliary Atresia, Kasai Portoenterostomy, Mesenchymal Stem Cell Transplantation","enrollment":14},{"nctId":"NCT06896747","phase":"PHASE1, PHASE2","title":"Evaluating Mechanically Engineered Stem Cell Exosomes for Treating Endometrial Injury: A Clinical Study","status":"RECRUITING","sponsor":"Tang-Du Hospital","startDate":"2025-02-21","conditions":"Thin Endometrial Lining, Female Infertility, Intrauterine Adhesions","enrollment":90},{"nctId":"NCT06839651","phase":"PHASE1","title":"Umbilical Cord Mesenchymal Stem Cell Secretome in Severe Erectile Dysfunction Non-responsive to Sildenafil","status":"NOT_YET_RECRUITING","sponsor":"Indonesia University","startDate":"2025-04-21","conditions":"Erectile Dysfunctions","enrollment":10},{"nctId":"NCT05292625","phase":"PHASE1, PHASE2","title":"Stem Cell Infusion in the Treatment of Patients with Neurological Sequelae After Ischemic Stroke","status":"COMPLETED","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2020-07-07","conditions":"Ischemic Stroke","enrollment":48},{"nctId":"NCT05286255","phase":"PHASE1","title":"Mesenchymal Stromal Cells for COVID-19 and Viral Pneumonias","status":"WITHDRAWN","sponsor":"Medical University of South Carolina","startDate":"2024-10-01","conditions":"COVID-19 Pneumonia, Viral Pneumonia","enrollment":""},{"nctId":"NCT05224960","phase":"PHASE2","title":"Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)","status":"RECRUITING","sponsor":"Beijing 302 Hospital","startDate":"2024-06-27","conditions":"Decompensated Cirrhosis","enrollment":140},{"nctId":"NCT06610773","phase":"PHASE1, PHASE2","title":"HUC-MSC for Treatment of High-risk HPV Infection","status":"RECRUITING","sponsor":"Shanghai East Hospital","startDate":"2024-03-01","conditions":"Human Papillomavirus Viruses, Mesenchymal Stem Cells","enrollment":60},{"nctId":"NCT06564740","phase":"NA","title":"Stem Cell Applications in Biliary Atresia Patients","status":"RECRUITING","sponsor":"Necmi Kadıoğlu Hospital","startDate":"2024-06-01","conditions":"Biliary Atresia, Fibrosis, Liver, Stem Cell","enrollment":64},{"nctId":"NCT06579352","phase":"","title":"Expanded Access Study of UC-MSC in DMD Patients","status":"AVAILABLE","sponsor":"MED Institute Inc.","startDate":"","conditions":"Duchenne Muscular Dystrophy","enrollment":""},{"nctId":"NCT06501066","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cells for Frailty Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Meribank Biotech Co., Ltd.","startDate":"2024-06-03","conditions":"Pathologic Processes","enrollment":66},{"nctId":"NCT06485648","phase":"EARLY_PHASE1","title":"Mesenchymal Stem Cell Transfusion for the Treatment of Refractory Lupus Nephritis","status":"NOT_YET_RECRUITING","sponsor":"Chinese PLA General Hospital","startDate":"2024-10-01","conditions":"Lupus Nephritis","enrollment":96},{"nctId":"NCT06448052","phase":"PHASE1, PHASE2","title":"Umbilical Cord Mesenchymal Stem Cell for Aging-related Low-grade Inflammation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nguyen Ton Ngoc Huynh","startDate":"2023-11-01","conditions":"Inflammatory Disease, Aging Problems, Obese","enrollment":72},{"nctId":"NCT04522869","phase":"PHASE1, PHASE2","title":"Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Biliary Atresia","status":"COMPLETED","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2019-08-10","conditions":"Primary Biliary Cirrhosis","enrollment":20},{"nctId":"NCT05345418","phase":"PHASE1, PHASE2","title":"Umbilical Cord-Derived Mesenchymal Stem Cell (VCELL 1) for Male Patients With Sexual Deficiency","status":"RECRUITING","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2022-04-01","conditions":"Sexual Dysfunction Male","enrollment":158},{"nctId":"NCT04433104","phase":"PHASE1, PHASE2","title":"Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2020-06-09","conditions":"COPD","enrollment":40},{"nctId":"NCT06431152","phase":"EARLY_PHASE1","title":"Intra-articular Injection of UC-MSC Exosome in Knee Osteoarthritis","status":"RECRUITING","sponsor":"Universidad de los Andes, Chile","startDate":"2024-06-01","conditions":"Osteo Arthritis Knee","enrollment":12},{"nctId":"NCT06388447","phase":"PHASE4","title":"Reconstruction of Deficient Interdental Papilla Using Stem Cells vs Physiological Saline","status":"ENROLLING_BY_INVITATION","sponsor":"University of Malaya","startDate":"2023-12-01","conditions":"Gingival Recession, Localized","enrollment":20},{"nctId":"NCT03902067","phase":"PHASE1","title":"UC-MSC Transplantation for Left Ventricular Dysfunction After AMI","status":"UNKNOWN","sponsor":"Shanghai Life Science & Technology","startDate":"2024-12-01","conditions":"Left Ventricular Dysfunction, Acute Myocardial Infarction","enrollment":40},{"nctId":"NCT06058078","phase":"PHASE2","title":"RY_SW01 Cell Injection Therapy in Active Lupus Nephritis","status":"RECRUITING","sponsor":"Jiangsu Renocell Biotech Company","startDate":"2023-08-17","conditions":"Lupus Nephritis","enrollment":60},{"nctId":"NCT06058091","phase":"PHASE1, PHASE2","title":"RY_SW01 Cell Injection Therapy in Systemic Sclerosis","status":"RECRUITING","sponsor":"Jiangsu Renocell Biotech Company","startDate":"2023-09-22","conditions":"Systemic Sclerosis","enrollment":81},{"nctId":"NCT05962762","phase":"PHASE1","title":"Safety and Tolerance of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in Patients With Ankylosing Spondylitis","status":"NOT_YET_RECRUITING","sponsor":"Asia Cell Therapeutics (Shanghai) Co., Ltd.","startDate":"2023-08-30","conditions":"Ankylosing Spondylitis","enrollment":9},{"nctId":"NCT05948982","phase":"PHASE1, PHASE2","title":"Safety of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in Patients With Decompensated Hepatitis B Cirrhosis","status":"NOT_YET_RECRUITING","sponsor":"Asia Cell Therapeutics (Shanghai) Co., Ltd.","startDate":"2023-07-30","conditions":"Decompensated Liver Cirrhosis","enrollment":18},{"nctId":"NCT05939817","phase":"PHASE4","title":"The Effect of Intralesian Injection of Umbilical Cord Mesenchymal Stem Cells, Its Conditioned Medium, and Triamcinolone Acetonide on Type 1:3 Collagen Ratio and Interleukin-10 Levels in Keloid: A Randomised Controlled Trial","status":"COMPLETED","sponsor":"Rumah Sakit Pusat Angkatan Darat Gatot Soebroto","startDate":"2021-10-01","conditions":"Keloid, Stem Cell","enrollment":24},{"nctId":"NCT05935423","phase":"PHASE3","title":"Umbilical Cord Mesenchymal Stem Cell Improve Cardiac Function on ST-elevation Myocardial Infarction (STEMI) Patients","status":"UNKNOWN","sponsor":"Indonesia University","startDate":"2023-07","conditions":"ST Elevation Myocardial Infarction","enrollment":60},{"nctId":"NCT05887804","phase":"PHASE4","title":"Comparison of Keloid Volume and Symptoms Reduction Between Intralesional Umbilical-Cord Mesenchymal Stem Cells, Its Conditioned Medium, and Triamcinolone Acetonide Injection as Keloid Therapy: A Randomised Controlled Trial","status":"COMPLETED","sponsor":"Rumah Sakit Pusat Angkatan Darat Gatot Soebroto","startDate":"2021-10-01","conditions":"Keloid, Stem Cell","enrollment":24},{"nctId":"NCT04738981","phase":"PHASE3","title":"Efficacy and Safety of UC-MSCs for the Treatment of Steroid-resistant aGVHD Following Allo-HSCT","status":"COMPLETED","sponsor":"Peking University People's Hospital","startDate":"2021-02-01","conditions":"Graft Vs Host Disease","enrollment":130},{"nctId":"NCT05751564","phase":"PHASE2","title":"\"Ready-to-use\" Intra-articular Formulation of Mesenchymal Stromal Cells","status":"UNKNOWN","sponsor":"Universidad de los Andes, Chile","startDate":"2023-04","conditions":"Osteo Arthritis Knee","enrollment":60},{"nctId":"NCT05512988","phase":"PHASE1, PHASE2","title":"Human Umbilical Cord Mesenchymal Stem Cell(UC-MSC)Delayed Renal Chronic Kidney Disease(CKD3、4 )","status":"UNKNOWN","sponsor":"Tongji Hospital","startDate":"2021-04-13","conditions":"Chronic Kidney Diseases","enrollment":44},{"nctId":"NCT05308342","phase":"NA","title":"Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Premature Ovarian Insufficiency","status":"UNKNOWN","sponsor":"Li-jun Ding","startDate":"2019-11-20","conditions":"Premature Ovarian Insufficiency","enrollment":66},{"nctId":"NCT04355728","phase":"PHASE1, PHASE2","title":"Use of UC-MSCs for COVID-19 Patients","status":"COMPLETED","sponsor":"Camillo Ricordi","startDate":"2020-04-25","conditions":"Corona Virus Infection, ARDS, ARDS, Human","enrollment":24},{"nctId":"NCT05106972","phase":"NA","title":"Umbilical Cord Mesenchymal Stem Cell Transplantation for Decompensated Hepatitis B Cirrhosis","status":"UNKNOWN","sponsor":"Asia Stem Cell Regenerative Pharmaceutical Co., Ltd.","startDate":"2021-12-01","conditions":"Liver Cirrhosis","enrollment":30},{"nctId":"NCT04822922","phase":"PHASE2","title":"Safety of UC-MSC Transfusion for ACLF Patients","status":"UNKNOWN","sponsor":"Hai Li","startDate":"2021-09-30","conditions":"Acute-On-Chronic Liver Failure","enrollment":16},{"nctId":"NCT04392778","phase":"PHASE1, PHASE2","title":"Clinical Use of Stem Cells for the Treatment of Covid-19","status":"COMPLETED","sponsor":"SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi","startDate":"2020-04-01","conditions":"Covid19, Pneumonia, Multiple Organ Failure","enrollment":30},{"nctId":"NCT04876326","phase":"NA","title":"Potential Use of Autologous and Allogeneic Mesenchymal Stem Cells in Patients With Multiple System Atrophy","status":"UNKNOWN","sponsor":"Indonesia University","startDate":"2020-10-05","conditions":"Multiple System Atrophy, Parkinsonism, Multiple System Atrophy, Parkinson Variant","enrollment":15},{"nctId":"NCT03609905","phase":"PHASE1, PHASE2","title":"Adipose Mesenchymal Stem Cells (AMSC) for Treatment of Ulcerative Colitis","status":"UNKNOWN","sponsor":"Liaocheng People's Hospital","startDate":"2018-07-01","conditions":"Ulcerative Colitis (UC)","enrollment":50},{"nctId":"NCT04501341","phase":"PHASE1, PHASE2","title":"BM-MNC and UCMSC for Type 2 Diabetes Mellitus Patients","status":"UNKNOWN","sponsor":"Indonesia University","startDate":"2016-03-14","conditions":"T2D","enrollment":15},{"nctId":"NCT04315025","phase":"PHASE1, PHASE2","title":"Safety Issues of Peribulbar Injection of UC-MSC in Patients With Retinitis Pigmentosa","status":"COMPLETED","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2018-10-07","conditions":"Retinitis Pigmentosa","enrollment":18},{"nctId":"NCT02235844","phase":"PHASE1","title":"Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)","status":"COMPLETED","sponsor":"Allergy and Asthma Consultants, Wichita, Kansas","startDate":"2014-09","conditions":"Duchenne's Muscular Dystrophy","enrollment":1},{"nctId":"NCT01985464","phase":"PHASE1, PHASE2","title":"Umbilical Cord Tissue-derived Mesenchymal Stem Cells for Rheumatoid Arthritis","status":"UNKNOWN","sponsor":"Translational Biosciences","startDate":"2013-10","conditions":"Rheumatoid Arthritis","enrollment":20},{"nctId":"NCT03943940","phase":"PHASE1, PHASE2","title":"BM-MNCs and UC-MSCs Infusion for Type 2 Diabetes Mellitus Patients","status":"UNKNOWN","sponsor":"Van Hanh General Hospital","startDate":"2019-04-24","conditions":"Type 2 Diabetes Mellitus","enrollment":60},{"nctId":"NCT03945487","phase":"PHASE2","title":"Mesenchymal Stem Cells Treatment for Decompensated Liver Cirrhosis","status":"UNKNOWN","sponsor":"Beijing 302 Hospital","startDate":"2019-05-20","conditions":"Decompensated Liver Cirrhosis","enrollment":200},{"nctId":"NCT03505034","phase":"PHASE2","title":"Intrathecal Transplantation of UC-MSC in Patients With Late Stage of Chronic Spinal Cord Injury","status":"UNKNOWN","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2019-09-01","conditions":"Spinal Cord Injuries","enrollment":43},{"nctId":"NCT03521323","phase":"PHASE2","title":"Intrathecal Transplantation of UC-MSC in Patients With Early Stage of Chronic Spinal Cord Injury","status":"UNKNOWN","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2019-09-01","conditions":"Spinal Cord Injuries","enrollment":66},{"nctId":"NCT03521336","phase":"PHASE2","title":"Intrathecal Transplantation of UC-MSC in Patients With Sub-Acute Spinal Cord Injury","status":"UNKNOWN","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2019-09-01","conditions":"Spinal Cord Injury","enrollment":84},{"nctId":"NCT02032446","phase":"PHASE1, PHASE2","title":"Umbilical Cord Derived Mesenchymal Stromal Cells For The Treatment of Severe Steroid-resistant Graft Versus Host Disease","status":"UNKNOWN","sponsor":"A.O. Ospedale Papa Giovanni XXIII","startDate":"2013-09","conditions":"Hematologic Malignancies","enrollment":47},{"nctId":"NCT02580695","phase":"PHASE1, PHASE2","title":"A Study to Assess Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells in Knee Osteoarthritis","status":"COMPLETED","sponsor":"Francisco Espinoza, MD","startDate":"2015-12","conditions":"Osteoarthritis","enrollment":30},{"nctId":"NCT01220492","phase":"PHASE1, PHASE2","title":"Umbilical Cord Mesenchymal Stem Cells for Patients With Liver Cirrhosis","status":"COMPLETED","sponsor":"Beijing 302 Hospital","startDate":"2009-05","conditions":"Liver Cirrhosis","enrollment":266},{"nctId":"NCT03166865","phase":"PHASE1, PHASE2","title":"Clinical Study of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) for Treatment of Knee Osteoarthritis","status":"UNKNOWN","sponsor":"Liaocheng People's Hospital","startDate":"2018-10-01","conditions":"Osteoarthritis of the Knee","enrollment":60},{"nctId":"NCT03529136","phase":"PHASE2","title":"Clinical Trial of Umbilical Cord Mesenchymal Stem Cell Transfusion in Decompensated Liver Cirrhosis","status":"UNKNOWN","sponsor":"Shandong Qilu Stem Cells Engineering Co., Ltd.","startDate":"2018-06-01","conditions":"Decompensated Liver Cirrhosis","enrollment":252},{"nctId":"NCT03484741","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cell Therapy for Type 1 Diabetes Mellitus Patients","status":"UNKNOWN","sponsor":"Van Hanh General Hospital","startDate":"2017-04-01","conditions":"Type 1 Diabetes Mellitus","enrollment":15},{"nctId":"NCT02192749","phase":"PHASE1, PHASE2","title":"Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy for Autism","status":"COMPLETED","sponsor":"Translational Biosciences","startDate":"2014-07","conditions":"Autism","enrollment":20},{"nctId":"NCT02237547","phase":"PHASE1, PHASE2","title":"Safety and Feasibility Study of Cell Therapy in Treatment of Spinal Cord Injury","status":"WITHDRAWN","sponsor":"Translational Biosciences","startDate":"2014-09","conditions":"Spinal Cord Injury","enrollment":""},{"nctId":"NCT02237846","phase":"PHASE1, PHASE2","title":"Clinical Study of Umbilical Cord Tissue Mesenchymal Stem Cells (UC-MSC) for Treatment of Osteoarthritis","status":"WITHDRAWN","sponsor":"Translational Biosciences","startDate":"2014-09","conditions":"Osteoarthritis of the Knee","enrollment":""},{"nctId":"NCT02812121","phase":"PHASE2","title":"UC-MSC Infusion for HBV-Related Acute-on-Chronic Liver Failure","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2016-06","conditions":"Liver Failure","enrollment":261},{"nctId":"NCT01754454","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of UC-MSC in Patients With Acute Severe Graft-versus-host Disease","status":"UNKNOWN","sponsor":"Affiliated Hospital to Academy of Military Medical Sciences","startDate":"2012-12","conditions":"Acute GVH Disease","enrollment":30},{"nctId":"NCT01547689","phase":"PHASE1, PHASE2","title":"Safety and Efficiency of Umbilical Cord-derived Mesenchymal Stem Cells(UC-MSC) in Patients With Alzheimer's Disease","status":"UNKNOWN","sponsor":"Affiliated Hospital to Academy of Military Medical Sciences","startDate":"2012-03","conditions":"Alzheimer's Disease","enrollment":30},{"nctId":"NCT02418325","phase":"PHASE1, PHASE2","title":"A Study of Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS","status":"TERMINATED","sponsor":"Genesis Limited","startDate":"2015-02","conditions":"Multiple Sclerosis, Relapsing-Remitting","enrollment":69},{"nctId":"NCT02587715","phase":"PHASE1, PHASE2","title":"A Study of Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS","status":"UNKNOWN","sponsor":"Novo Cellular Medicine Institute LLP","startDate":"2015-02","conditions":"Multiple Sclerosis, Relapsing-Remitting","enrollment":69},{"nctId":"NCT01573923","phase":"PHASE1, PHASE2","title":"Safety and Efficacy Study of Umbilical Mesenchymal Stem Cells for Liver Cirrhosis","status":"UNKNOWN","sponsor":"Alliancells Bioscience Corporation Limited","startDate":"2014-07","conditions":"Liver Cirrhosis","enrollment":320},{"nctId":"NCT01844063","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Diverse Mesenchymal Stem Cells Transplantation for Liver Failure","status":"UNKNOWN","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2013-07","conditions":"Liver Failure","enrollment":210},{"nctId":"NCT01547091","phase":"PHASE1, PHASE2","title":"Safety and Efficacy Study of Umbilical Cord-Derived Mesenchymal Stem Cells for Rheumatoid Arthritis","status":"UNKNOWN","sponsor":"Alliancells Bioscience Corporation Limited","startDate":"2013-04","conditions":"Rheumatoid Arthritis","enrollment":200},{"nctId":"NCT01218464","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Human Mesenchymal Stem Cells for Treatment of Liver Failure","status":"UNKNOWN","sponsor":"Beijing 302 Hospital","startDate":"2009-03","conditions":"Liver Failure, Mesenchymal Stem Cells","enrollment":70},{"nctId":"NCT01662973","phase":"PHASE1, PHASE2","title":"Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis","status":"UNKNOWN","sponsor":"Beijing 302 Hospital","startDate":"2011-10","conditions":"Primary Biliary Cirrhosis","enrollment":100},{"nctId":"NCT01690247","phase":"PHASE1","title":"Human Mesenchymal Stem Cells Induce Liver Transplant Tolerance","status":"UNKNOWN","sponsor":"Beijing 302 Hospital","startDate":"2012-02","conditions":"Evidence of Liver Transplantation","enrollment":50},{"nctId":"NCT01661842","phase":"PHASE1, PHASE2","title":"Umbilical Cord Mesenchymal Stem Cells for Patients With Autoimmune Hepatitis","status":"UNKNOWN","sponsor":"Beijing 302 Hospital","startDate":"2011-10","conditions":"Autoimmune Hepatitis","enrollment":100},{"nctId":"NCT01213186","phase":"PHASE2","title":"Umbilical Cord Mesenchymal Stem Cells for Immune Reconstitution in HIV-infected Patients","status":"UNKNOWN","sponsor":"Fu-Sheng Wang","startDate":"2013-01","conditions":"Human Immunodeficiency Virus, Disorder of Immune Reconstitution","enrollment":72},{"nctId":"NCT01724398","phase":"PHASE1, PHASE2","title":"Umbilical Cord Mesenchymal Stem Cells Transplantation Combined With Plasma Exchange for Patients With Liver Failure","status":"UNKNOWN","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2012-11","conditions":"Liver Failure","enrollment":120},{"nctId":"NCT01728727","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Human Umbilical Cord Derived Mesenchymal Stem Cells for Treatment of HBV-related Liver Cirrhosis","status":"UNKNOWN","sponsor":"Air Force Military Medical University, China","startDate":"2012-09","conditions":"Liver Cirrhosis, End Stage Liver Disease","enrollment":240}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":438,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Umbilical Cord- Mesenchymal Stem Cell (UC-MSC)","Human umbilical cord mesenchymal stem cells","Umbilical cord-derived mesenchymal stem cells","Transplantation Group"],"phase":"phase_3","status":"active","brandName":"UC-MSC","genericName":"UC-MSC","companyName":"PT. Prodia Stem Cell Indonesia","companyId":"pt-prodia-stem-cell-indonesia","modality":"Biologic","firstApprovalDate":"","aiSummary":"UC-MSC is an umbilical cord-derived mesenchymal stem cell therapy that promotes tissue regeneration and modulates immune responses through paracrine signaling. Used for Ulcerative colitis (phase 3).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":3,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}